Towards Healthcare
RNA Analysis Market to Rise at 13.36% till 2035

RNA Analysis Market Driven by Single-Cell Sequencing

According to market projections, the RNA analysis sector is expected to grow from USD 6.86 billion in 2025 to USD 23.9 billion by 2035, reflecting a CAGR of 13.36%. The RNA analysis market is growing due to increasing demand for personalized medicine. North America is leading due to its advanced research infrastructure and favorable government environment.

Content

  • Last Updated: 04 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The RNA analysis market in 2026 is valued at USD 7.78 billion and is projected to climb to USD 2.5 billion by 2034, with a CAGR of 13.36% over the forecast period.

North America is currently leading the RNA analysis market share by 44% due to advanced healthcare infrastructure and favorable regulatory frameworks.

The RNA analysis market includes six segments by service technology methodology, by product offering, by application, by end user, and by region.

Some key players include Illumina, Inc., Thermo Fisher Scientific, iagen, Agilent Technologies, Bio-Rad Laboratories, and Oxford Nanopore Technologies.

A major goal of RNA-seq analysis is to identify differentially expressed and coregulated genes and to infer biological meaning for further studies.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions